NKT.CO vs. REGN
NKT.CO (NKT A/S) and REGN (Regeneron Pharmaceuticals, Inc.) are both stocks. NKT.CO operates in Electrical Equipment & Parts (Industrials), while REGN operates in Biotechnology (Healthcare). Over the past 10 years, NKT.CO returned 22.07%/yr vs 4.42%/yr for REGN. At a 0.11 correlation, their price movements are largely independent.
Performance
NKT.CO vs. REGN - Performance Comparison
Loading charts...
Different Trading Currencies
NKT.CO is traded in DKK, while REGN is traded in USD. To make them comparable, the REGN values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, NKT.CO achieves a 27.74% return, which is significantly higher than REGN's -17.36% return. Over the past 10 years, NKT.CO has outperformed REGN with an annualized return of 22.07%, while REGN has yielded a comparatively lower 4.42% annualized return.
NKT.CO
- 1D
- -1.92%
- 1M
- 7.77%
- YTD
- 27.74%
- 6M
- 29.69%
- 1Y
- 94.10%
- 3Y*
- 37.41%
- 5Y*
- 31.00%
- 10Y*
- 22.07%
REGN
- 1D
- 1.43%
- 1M
- -9.74%
- YTD
- -17.36%
- 6M
- -12.50%
- 1Y
- 28.41%
- 3Y*
- -7.88%
- 5Y*
- 5.44%
- 10Y*
- 4.42%
NKT.CO vs. REGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NKT.CO NKT A/S | 27.74% | 55.20% | 10.93% | 29.06% | 24.02% | 16.37% | 91.04% | 80.78% | -68.60% | 20.78% |
REGN Regeneron Pharmaceuticals, Inc. | -17.36% | -3.80% | -13.50% | 18.38% | 21.38% | 40.30% | 17.60% | 2.88% | 4.26% | -10.08% |
Correlation
The correlation between NKT.CO and REGN is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Aug 30, 2007 | 0.11 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NKT.CO vs. REGN — Risk / Return Rank
NKT.CO
REGN
NKT.CO vs. REGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NKT A/S (NKT.CO) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NKT.CO | REGN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.73 | ||
| Sortino ratioReturn per unit of downside risk | +2.27 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.18 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 8.27 | 1.12 | +7.15 |
| Martin ratioReturn relative to average drawdown | 22.26 | 3.75 | +18.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NKT.CO | REGN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.61 | 0.89 | +1.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.86 | 0.18 | +0.69 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.56 | 0.14 | +0.42 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.51 | -0.13 |
Drawdowns
NKT.CO vs. REGN - Drawdown Comparison
The maximum NKT.CO drawdown since its inception was -91.71%, which is greater than REGN's maximum drawdown of -60.81%. Use the drawdown chart below to compare losses from any high point for NKT.CO and REGN.
Loading charts...
Drawdown Indicators
| NKT.CO | REGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.71% | -60.81% | -30.90% |
Max Drawdown (1Y)Largest decline over 1 year | -11.63% | -25.57% | +13.94% |
Max Drawdown (3Y)Largest decline over 3 years | -34.39% | -60.81% | +26.42% |
Max Drawdown (5Y)Largest decline over 5 years | -34.39% | -60.81% | +26.42% |
Max Drawdown (10Y)Largest decline over 10 years | -74.42% | -60.81% | -13.61% |
Current DrawdownCurrent decline from peak | -8.27% | -49.38% | +41.11% |
Average DrawdownAverage peak-to-trough decline | -33.50% | -20.87% | -12.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.82% | 7.59% | -2.77% |
Volatility
NKT.CO vs. REGN - Volatility Comparison
The current volatility for NKT A/S (NKT.CO) is 11.27%, while Regeneron Pharmaceuticals, Inc. (REGN) has a volatility of 12.61%. This indicates that NKT.CO experiences smaller price fluctuations and is considered to be less risky than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NKT.CO | REGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.27% | 12.61% | -1.34% |
Volatility (6M)Calculated over the trailing 6-month period | 23.41% | 21.88% | +1.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.79% | 32.16% | +4.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.08% | 31.19% | +4.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.03% | 32.87% | +7.16% |
Dividends
NKT.CO vs. REGN - Dividend Comparison
NKT.CO has not paid dividends to shareholders, while REGN's dividend yield for the trailing twelve months is around 0.58%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NKT.CO NKT A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.96% | 0.80% | 1.12% |
REGN Regeneron Pharmaceuticals, Inc. | 0.58% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NKT.CO vs. REGN - Financials Comparison
This section allows you to compare key financial metrics between NKT A/S and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NKT.CO and REGN have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NKT.CO and REGN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer